Zimmer cuts 2025 organic sales growth forecast on weakness in international markets

Core Viewpoint - Zimmer Biomet Holdings has revised its 2025 organic revenue growth forecast downward due to underperformance in Latin America and emerging markets in Europe, despite strong results in the U.S., leading to an 8.4% drop in shares during premarket trading [1] Group 1 - The company has cut its 2025 organic revenue growth forecast [1] - Weakness in Latin America and emerging markets in Europe has negatively impacted the company's outlook [1] - Strong performance in the U.S. was not enough to offset the declines in other regions [1]